GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rekah Pharmaceutical Prod Ltd (XTAE:REKA) » Definitions » Forward Dividend Yield %

Rekah Pharmaceutical Prod (XTAE:REKA) Forward Dividend Yield % : 0.00% (As of Mar. 29, 2025)


View and export this data going back to 2002. Start your Free Trial

What is Rekah Pharmaceutical Prod Forward Dividend Yield %?

As of today (2025-03-29), the Forward Annual Dividend Yield of Rekah Pharmaceutical Prod is 0.00%.

As of today (2025-03-29), the Trailing Annual Dividend Yield of Rekah Pharmaceutical Prod is 0.00%.

XTAE:REKA's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.84
* Ranked among companies with meaningful Forward Dividend Yield % only.

Rekah Pharmaceutical Prod's Dividends per Share for the three months ended in Sep. 2024 was ₪0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Rekah Pharmaceutical Prod's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Rekah Pharmaceutical Prod's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rekah Pharmaceutical Prod's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rekah Pharmaceutical Prod's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Rekah Pharmaceutical Prod's Forward Dividend Yield % falls into.


;
;

Rekah Pharmaceutical Prod Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Rekah Pharmaceutical Prod  (XTAE:REKA) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Rekah Pharmaceutical Prod Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Rekah Pharmaceutical Prod's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rekah Pharmaceutical Prod Business Description

Traded in Other Exchanges
N/A
Address
30 Hamelacha Street, Holon, ISR
Rekah Pharmaceutical Prod Ltd is engaged in the manufacturing, importing, marketing, and distribution of pharmaceuticals and cosmetics. It primarily caters to the needs of hospitals, retirement homes, and national medical healthcare services.

Rekah Pharmaceutical Prod Headlines

No Headlines